GB9111425D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9111425D0
GB9111425D0 GB919111425A GB9111425A GB9111425D0 GB 9111425 D0 GB9111425 D0 GB 9111425D0 GB 919111425 A GB919111425 A GB 919111425A GB 9111425 A GB9111425 A GB 9111425A GB 9111425 D0 GB9111425 D0 GB 9111425D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
bioprecursors
hypoglycaemic
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919111425A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB919111425A priority Critical patent/GB9111425D0/en
Publication of GB9111425D0 publication Critical patent/GB9111425D0/en
Priority to NZ242642A priority patent/NZ242642A/en
Priority to MW23/92A priority patent/MW2392A1/xx
Priority to ZA923355A priority patent/ZA923355B/xx
Priority to IL101820A priority patent/IL101820A0/xx
Priority to CA002068378A priority patent/CA2068378A1/en
Priority to ZW72/92A priority patent/ZW7292A1/xx
Priority to HU9201610A priority patent/HU211732B/hu
Priority to KR1019920008404A priority patent/KR920021491A/ko
Priority to AU17043/92A priority patent/AU653229B2/en
Priority to DK92304654.4T priority patent/DK0516350T3/da
Priority to DE69204908T priority patent/DE69204908T2/de
Priority to ES92304654T priority patent/ES2077354T3/es
Priority to EP92304654A priority patent/EP0516350B1/en
Priority to GB929210927A priority patent/GB9210927D0/en
Priority to AT92304654T priority patent/ATE128116T1/de
Priority to YU54692A priority patent/YU54692A/sh
Priority to MYPI92000891A priority patent/MY137475A/en
Priority to CN92103976A priority patent/CN1069022A/zh
Priority to CS921591A priority patent/CS159192A3/cs
Priority to NO92922114A priority patent/NO922114L/no
Priority to SI19929200091A priority patent/SI9200091A/sl
Priority to FI922423A priority patent/FI922423A7/fi
Priority to JP4134841A priority patent/JPH0687801A/ja
Priority to PL29470592A priority patent/PL294705A1/xx
Priority to MX9202501A priority patent/MX9202501A/es
Priority to RO92-200739A priority patent/RO111457B1/ro
Priority to TW081104314A priority patent/TW215917B/zh
Priority to IE144692A priority patent/IE921446A1/en
Priority to US08/057,763 priority patent/US5502078A/en
Priority to GR950402785T priority patent/GR3017681T3/el
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/06—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C07C251/08—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton being acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
GB919111425A 1991-05-28 1991-05-28 Chemical compounds Pending GB9111425D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB919111425A GB9111425D0 (en) 1991-05-28 1991-05-28 Chemical compounds
NZ242642A NZ242642A (en) 1991-05-28 1992-05-07 3'- and/or 5'-substituted 4-[2-(2-hydroxy-2-phenylamino)ethoxy]phenylacetic acid derivatives, medicaments and precursors
MW23/92A MW2392A1 (en) 1991-05-28 1992-05-07 Chemical compounds
ZA923355A ZA923355B (en) 1991-05-28 1992-05-08 2-hydroxy-2-phenylethyl lamino compounds
IL101820A IL101820A0 (en) 1991-05-28 1992-05-10 Chemical compounds
CA002068378A CA2068378A1 (en) 1991-05-28 1992-05-11 Chemical compounds
ZW72/92A ZW7292A1 (en) 1991-05-28 1992-05-11 Chemical compounds
HU9201610A HU211732B (en) 1991-05-28 1992-05-15 Process to prepare 2-hydroxy-2-phenylethylamino compounds and pharmaceutical comns. contg. them
KR1019920008404A KR920021491A (ko) 1991-05-28 1992-05-19 2-히드록시-2-페닐에틸아미노 화합물
AU17043/92A AU653229B2 (en) 1991-05-28 1992-05-21 2-(2-hydroxy-2-phenylethylamino)ethoxyphenylacetyl compounds
AT92304654T ATE128116T1 (de) 1991-05-28 1992-05-22 2-hydroxy-2-phenylethylaminderivate als beta-3- adrenoceptor agonisten.
GB929210927A GB9210927D0 (en) 1991-05-28 1992-05-22 Chemical compounds
DE69204908T DE69204908T2 (de) 1991-05-28 1992-05-22 2-Hydroxy-2-phenylethylaminderivate als Beta-3-adrenoceptor Agonisten.
ES92304654T ES2077354T3 (es) 1991-05-28 1992-05-22 Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores.
EP92304654A EP0516350B1 (en) 1991-05-28 1992-05-22 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
DK92304654.4T DK0516350T3 (da) 1991-05-28 1992-05-22 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
YU54692A YU54692A (sh) 1991-05-28 1992-05-25 Hemijska jedinjenja
MYPI92000891A MY137475A (en) 1991-05-28 1992-05-25 Chemical compounds.
CN92103976A CN1069022A (zh) 1991-05-28 1992-05-26 用于治疗肥胖及相关状态的4-[2-(2-羟基-2-苯乙氨基)乙氧基]苯乙酸衍生物
CS921591A CS159192A3 (en) 1991-05-28 1992-05-26 2-hydroxy-2-phenylethylamino derivatives, process of their preparation andtheir use
MX9202501A MX9202501A (es) 1991-05-28 1992-05-27 Compuestos quimicos.
SI19929200091A SI9200091A (en) 1991-05-28 1992-05-27 4-(2-(2-hydroxy-2-phenylethylamino)ethoxy)phenylacetic acid derivatives used in therapy obesity and related state
NO92922114A NO922114L (no) 1991-05-28 1992-05-27 Kjemiske forbindelser
FI922423A FI922423A7 (fi) 1991-05-28 1992-05-27 Kemiallisia yhdisteitä
JP4134841A JPH0687801A (ja) 1991-05-28 1992-05-27 ２−ヒドロキシ−２−フェニルエチルアミノ化合物、その製法及びこれを含有する医薬組成物
PL29470592A PL294705A1 (en) 1991-05-28 1992-05-27 Method of obtaining 2-hydroxy-2-phenylamine compounds or their bioprecursor substances or pharmaceutically admissible salts
RO92-200739A RO111457B1 (ro) 1991-05-28 1992-05-28 Compusi de feniletanolamina, bioprecursori ai acestora, procedee de preparare, intermediari, compozitie farmaceutica care ii contine si metoda de tratament
TW081104314A TW215917B (cg-RX-API-DMAC7.html) 1991-05-28 1992-06-02
IE144692A IE921446A1 (en) 1991-05-28 1992-07-01 Chemical compounds
US08/057,763 US5502078A (en) 1991-05-28 1993-05-07 Chemical compounds
GR950402785T GR3017681T3 (en) 1991-05-28 1995-10-10 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111425A GB9111425D0 (en) 1991-05-28 1991-05-28 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9111425D0 true GB9111425D0 (en) 1991-07-17

Family

ID=10695678

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919111425A Pending GB9111425D0 (en) 1991-05-28 1991-05-28 Chemical compounds
GB929210927A Pending GB9210927D0 (en) 1991-05-28 1992-05-22 Chemical compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB929210927A Pending GB9210927D0 (en) 1991-05-28 1992-05-22 Chemical compounds

Country Status (28)

Country Link
EP (1) EP0516350B1 (cg-RX-API-DMAC7.html)
JP (1) JPH0687801A (cg-RX-API-DMAC7.html)
KR (1) KR920021491A (cg-RX-API-DMAC7.html)
CN (1) CN1069022A (cg-RX-API-DMAC7.html)
AT (1) ATE128116T1 (cg-RX-API-DMAC7.html)
AU (1) AU653229B2 (cg-RX-API-DMAC7.html)
CA (1) CA2068378A1 (cg-RX-API-DMAC7.html)
CS (1) CS159192A3 (cg-RX-API-DMAC7.html)
DE (1) DE69204908T2 (cg-RX-API-DMAC7.html)
DK (1) DK0516350T3 (cg-RX-API-DMAC7.html)
ES (1) ES2077354T3 (cg-RX-API-DMAC7.html)
FI (1) FI922423A7 (cg-RX-API-DMAC7.html)
GB (2) GB9111425D0 (cg-RX-API-DMAC7.html)
GR (1) GR3017681T3 (cg-RX-API-DMAC7.html)
HU (1) HU211732B (cg-RX-API-DMAC7.html)
IE (1) IE921446A1 (cg-RX-API-DMAC7.html)
IL (1) IL101820A0 (cg-RX-API-DMAC7.html)
MW (1) MW2392A1 (cg-RX-API-DMAC7.html)
MY (1) MY137475A (cg-RX-API-DMAC7.html)
NO (1) NO922114L (cg-RX-API-DMAC7.html)
NZ (1) NZ242642A (cg-RX-API-DMAC7.html)
PL (1) PL294705A1 (cg-RX-API-DMAC7.html)
RO (1) RO111457B1 (cg-RX-API-DMAC7.html)
SI (1) SI9200091A (cg-RX-API-DMAC7.html)
TW (1) TW215917B (cg-RX-API-DMAC7.html)
YU (1) YU54692A (cg-RX-API-DMAC7.html)
ZA (1) ZA923355B (cg-RX-API-DMAC7.html)
ZW (1) ZW7292A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE215365T1 (de) * 1992-01-22 2002-04-15 Glaxo Group Ltd Medizinische verwendung von atypischen beta- adrenoceptor agonisten
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
EP1258253A1 (en) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
CN101544578B (zh) * 2009-03-24 2012-04-25 贵阳医学院 苯乙酸衍生物其制备方法以及其在药物中的应用
CN103977015B (zh) * 2014-05-05 2016-10-05 南京瑞菁医药科技有限责任公司 中药毛菊苣降脂活性成分配伍组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB212801A (en) * 1923-06-18 1924-03-20 Alfred George Osborne Strong Improvements in machines for lining tins with paper bags
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
GB2212801A (en) * 1987-11-26 1989-08-02 Resolution Chemicals Limited Preparation of an alkanolamine derivatives
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds

Also Published As

Publication number Publication date
FI922423L (fi) 1992-11-29
ATE128116T1 (de) 1995-10-15
CA2068378A1 (en) 1992-11-29
HU9201610D0 (en) 1992-08-28
ES2077354T3 (es) 1995-11-16
HUT61968A (en) 1993-03-29
NZ242642A (en) 1994-12-22
FI922423A0 (fi) 1992-05-27
MW2392A1 (en) 1993-03-10
AU653229B2 (en) 1994-09-22
GB9210927D0 (en) 1992-07-08
RO111457B1 (ro) 1996-10-31
KR920021491A (ko) 1992-12-18
MY137475A (en) 2009-01-30
FI922423A7 (fi) 1992-11-29
ZA923355B (en) 1993-04-28
TW215917B (cg-RX-API-DMAC7.html) 1993-11-11
IL101820A0 (en) 1992-12-30
PL294705A1 (en) 1993-07-26
CS159192A3 (en) 1992-12-16
EP0516350B1 (en) 1995-09-20
IE921446A1 (en) 1992-12-02
HU211732B (en) 1995-12-28
ZW7292A1 (en) 1993-02-03
YU54692A (sh) 1995-10-03
CN1069022A (zh) 1993-02-17
JPH0687801A (ja) 1994-03-29
AU1704392A (en) 1992-12-03
DK0516350T3 (da) 1995-12-04
DE69204908D1 (de) 1995-10-26
SI9200091A (en) 1992-12-31
EP0516350A2 (en) 1992-12-02
NO922114D0 (no) 1992-05-27
DE69204908T2 (de) 1996-02-08
GR3017681T3 (en) 1996-01-31
NO922114L (no) 1992-11-30
EP0516350A3 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
GB8817651D0 (en) Chemical compounds
ZW385A1 (en) Chemical compounds
HU900064D0 (en) Process for preparation of new 2-amino pyrimidinone-derivatives
NZ225408A (en) Acetohydroxamic acid derivatives and compositions thereof
GB9210927D0 (en) Chemical compounds
AU582235B2 (en) Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs
DE3574256D1 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
AU1507888A (en) New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
PH19042A (en) Nitro aliphatic compounds,its pharmaceutical composition and use thereof
AU7266291A (en) A novel substituted-amine compound and a process for the preparation thereof
HU913520D0 (en) Process for the production of 7-acyl-3(substituted carbamoiloxy)-cefem-derivatives and of the medical preparations containing them
HUT39147A (en) Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
ES2032413T3 (es) Procedimiento para preparar pirimidoquinoxalinas sustituidas. (reserva del art. 167.2 cpe).
PH22441A (en) Quinate salts of the antimaterial compound mefloquine
ES482083A1 (es) Un procedimiento para la preparacion de un derivado de teta-hidro-2h-benzo-c-pirrol.